Astellas accuses Cipla of infringing overactive bladder patent

07-06-2018

Astellas accuses Cipla of infringing overactive bladder patent

TheDman / iStockphoto.com

Pharmaceutical company Astellas Pharma has filed a patent infringement claim against India-based Cipla over a drug for treating an overactive bladder.


Astellas Pharma, Cipla, patent, patent infringement, FDA, generic, Teva Pharmaceuticals

LSIPR